HMG-CoA Reductase Inhibitor [EPC]

334489 reported adverse events

Drugs of this class: SIMVASTATIN LOVASTATIN EZETIMIBE AND SIMVASTATIN ATORVASTATIN CALCIUM PITAVASTATIN MAGNESIUM ROSUVASTATIN

These side effects are most commonly reported by patients taking drugs of the HMG-CoA Reductase Inhibitor [EPC] class:

#	Side effect	Count
0	FATIGUE	18004
1	NAUSEA	16854
2	DRUG INEFFECTIVE	16754
3	DYSPNOEA	16134
4	DIARRHOEA	15123
5	DIZZINESS	14141
6	ASTHENIA	12139
7	PAIN	12095
8	FALL	11692
9	HEADACHE	11311

See all common reactions for HMG-CoA Reductase Inhibitor [EPC]

Drugs of the HMG-CoA Reductase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

#	Side effect	Count	Frequency
0	IMMUNE-MEDIATED NECROTISING MYOPATHY	251	0.4580
1	IMMUNE-MEDIATED MYOSITIS	321	0.3821
2	CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER	246	0.2645
3	MYOPATHY	1716	0.2562
4	HYPERPARATHYROIDISM SECONDARY	549	0.2465
5	NEPHROGENIC ANAEMIA	975	0.2314
6	RHABDOMYOLYSIS	7135	0.2223
7	REBOUND ACID HYPERSECRETION	536	0.1843
8	POLYMYOSITIS	206	0.1456
9	SEDATION COMPLICATION	213	0.1448

See all enriched reactions for HMG-CoA Reductase Inhibitor [EPC]